Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Stage II”

681 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 681 results

Testing effectiveness (Phase 2)UnknownNCT01429961
What this trial is testing

Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Seoul National University Hospital 38
Testing effectiveness (Phase 2)Study completedNCT02716766
What this trial is testing

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, HepatocellularSecondary
The University of Hong Kong 46
Testing effectiveness (Phase 2)Study completedNCT00614913
What this trial is testing

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
Loma Linda University 76
Testing effectiveness (Phase 2)UnknownNCT04913480
What this trial is testing

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The University of Hong Kong 37
Not applicableStudy completedNCT02774161
What this trial is testing

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Who this might be right for
CirrhosisEarly Hepatocellular CarcinomaFibrosis+2 more
Stanford University 45
Testing effectiveness (Phase 2)Study completedNCT00844883
What this trial is testing

Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatoma
Yale University 50
Not applicableEnded earlyNCT02147301
What this trial is testing

TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve

Who this might be right for
Hepatocellular CarcinomaChemoembolization
University of California, San Francisco 17
Testing effectiveness (Phase 2)UnknownNCT02311205
What this trial is testing

Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)

Who this might be right for
Hepatocellular CarcinomaMetastasis
Asan Medical Center 55
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT03033446
What this trial is testing

Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma

Who this might be right for
HepatoCellular Carcinoma
National Cancer Centre, Singapore 40
Testing effectiveness (Phase 2)Study completedNCT00083226
What this trial is testing

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT06789848
What this trial is testing

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Who this might be right for
Advanced Hepatocellular CarcinomaRefractory Hepatocellular CarcinomaBiliary Tract Cancer
University of Texas Southwestern Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT00542048
What this trial is testing

A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

Who this might be right for
Liver CancerNeoplasm Metastasis
MediGene 20
Not applicableUnknownNCT05114148
What this trial is testing

Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
UMC Utrecht 30
Testing effectiveness (Phase 2)Study completedNCT05532319
What this trial is testing

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC

Who this might be right for
Liver Cancer
Guangxi Medical University 64
Testing effectiveness (Phase 2)Ended earlyNCT02524119
What this trial is testing

LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT02089763
What this trial is testing

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Bio-Cancer Treatment International Limited 27
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01116635
What this trial is testing

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of British Columbia 24
Next Page